Best Pharma Consulting Company

 What is BYDUREON BCISE? how to use?

BYDUREON BCISE is an injectable prescription drug that improves blood sugar (glucose) in adults with type 2 diabetes. It should be used with diet and exercise.

It is not recommended to use BYDUREON BCISE as the first choice for the treatment of diabetes.

BYDUREON BCISE is not suitable for patients with type 1 diabetes.

pharma consulting company

BYDUREON BCISE and BYDUREON are long-acting forms of BYETTA (exenatide). BYDUREON BCISE cannot be used simultaneously with BYETTA or BYDUREON.

It is not known whether BYDUREON BCISE can be used in people with pancreatitis.

It is not known whether BYDUREON BCISE is safe and effective in children.

What are the possible side effects of BYDUREON BCISE?

BYDUREON BCISE may cause serious side effects, including:

See "What is the most important information I should know about BYDUREON BCISE?"

Inflammation of the pancreas (pancreatitis). If your abdomen (abdomen) is severely painful, regardless of vomiting or not, stop using BYDUREON BCISE and call your healthcare provider immediately. You may feel pain from the abdomen to the back.

pharma consulting company

Hypoglycemia (hypoglycemia). If you use BYDUREON BCISE with other drugs that may cause hypoglycemia (such as sulfonylureas or insulin), your risk of developing hypoglycemia may be higher. Signs and symptoms of low blood sugar may include:

  • Dizziness or lightheadedness
  • Blurred vision
  • Anxiety, irritability or mood changes
  • Sweating
  • Slurred speech
  • hunger
  • Confusion or drowsiness
  • Trembling
  • weakness
  • headache
  • Fast heartbeat
  • feel nervous

Kidney problems. In people with kidney problems, diarrhea, nausea, and vomiting can cause fluid loss (dehydration), which can lead to worsening kidney problems or kidney failure.

Stomach problems. Other drugs like BYDUREON BCISE may also cause serious stomach problems. It is not known whether BYDUREON BCISE causes or aggravates stomach problems.

Low platelet count (thrombocytopenia caused by drugs). BYDUREON BCISE may cause a decrease in the number of platelets in the blood. When the platelet count is too low, your body will not be able to form a blood clot. You may have severe bleeding, which may result in death. If you have abnormal bleeding or bruising, stop using BYDUREON BCISE and call your healthcare provider immediately. About 10 weeks after stopping BYDUREON BCISE, your platelet count may continue to be low.

Severe allergic reaction. If you have any symptoms of a severe allergic reaction, including itching, rash, or difficulty breathing, stop using BYDUREON BCISE and seek medical help immediately.

Injection site reaction. In some people using BYDUREON, severe injection site reactions have occurred with or without bumps (nodules). Some of these injection site reactions require surgical treatment. If you have any symptoms of injection site reactions, including severe pain, swelling, blisters, open wounds, acne sc, please call your healthcare provider.

Gallbladder problems. People taking other medicines such as BYDUREON or BYDUREON have developed gallbladder problems. If you have symptoms of gallbladder problems, tell your healthcare provider immediately. These symptoms may include pain in the middle or upper middle of the right stomach, nausea and vomiting, fever, or yellowing of the white parts of your skin or eyes.

The most common side effects of BYDUREON BCISE may include lumps (nodules) and nausea at the injection site.

Nausea is the most common when you first start using BYDUREON BCISE, but over time, most people will decrease as the body adapts to this drug.

Talk to your healthcare provider about any side effects that bother you or do not go away.

These are not all possible side effects of BYDUREON BCISE.

Description

BYDUREON BCISE (Exenatide Sustained Release) Injection Suspension is a GLP-1 receptor agonist, used as a single-dose auto-injector in a medium chain triglyceride (MCT) oil-based medium as a sustained release of Exenatide A sterile suspension of microspheres is provided. Re-dispersion by mixing provides a white to off-white opaque suspension that can be administered by subcutaneous injection. Each auto-injector contains enough suspension to release 2 mg of Exenatide Extended Release in a volume of 0.85 mL.

Exenatide is a synthetic peptide amide with 39 amino acids. Its empirical formula is C184H282N50O60S and its molecular weight is 4186.6 Daltons. The amino acid sequence of Exenatide is shown below.

H-His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-IleGlu-Trp- Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2

Exenatide is incorporated into a sustained-release microsphere formulation containing 50:50 poly(D, lactide-co-glycolide) polymer (37.2 mg per dose) and sucrose (0.8 mg per dose), And suspended in the vehicle MCT (774.4 mg/dose).

It is very challenging to find a good pharma consulting company which is rapidly growing with remarkable note, but there are some companies that provides numerous amount of pharmaceutical consulting services


Comments

Post a Comment

Popular posts from this blog

Best Pharma Consulting Company

Image
 Drug Name Atriance 5 mg/ml infusion solution 2. Qualitative and quantitative composition Each milliliter of solution contains 5 mg of Nelarabine. Each vial contains 250 mg of Nelarabine. Excipients with known effects Each milliliter of solution contains 1.770 mg (77 micromoles) of sodium. For a complete list of excipients, see section 6.1. 3. Drug form Infusion solution. Clear colorless solution. 4. Clinical details 4.1 Treatment indications Nelarabine is suitable for the treatment of patients with T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL) who have not responded or relapsed after treatment with at least two chemotherapy regimens. Because the number of patients in these conditions is small, the information supporting these indications is based on limited data. 4.2 Modes and methods of administration Nelarabine can only be administered under the guidance of a doctor who has experience in the use of cytotoxic agents. Ontology The complete b...
Read more

Best Pharma Consulting Company

Image
  Indications Instruct VENCLEXTA: For the treatment of adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). Combine with azacitidine, decitabine or low-dose cytarabine for the treatment of newly diagnosed adult acute myeloid leukemia (AML): 75 years or older, or Patients with comorbidities cannot use intensive induction chemotherapy. Important safety information Contraindications In patients with CLL/SLL, simultaneous use of VENCLEXTA with strong CYP3A inhibitors is contraindicated because it may increase the risk of tumor lysis syndrome (TLS). Tumor lysis syndrome Patients treated with VENCLEXTA developed tumor lysis syndromes, including fatal events and renal failure requiring dialysis. VENCLEXTA can cause rapid tumor reduction, so in all CLL/SLL patients, there is a risk of TLS during the start and the start phase, and during the restart period after the dose is interrupted. Changes in blood chemistry consistent with TLS need to be dealt wi...
Read more

Best Pharma Consulting Company

Image
  About Veenat 400 mg tablets 10 Veenat 400 mg tablets belong to a class of drugs called "anti-cancer drugs" and are mainly used to treat various types of cancer. It is used to treat blood cancers (chronic myeloid leukemia and acute lymphocytic leukemia) and gastrointestinal stromal tumors. Cancer is a genetic change in which our cells divide uncontrollably and spread into surrounding tissues. There are more than 100 kinds of cancer, including blood cancer, lung cancer, breast cancer and so on. 10 Veenat 400 mg tablets contain imatinib, which is mainly used to treat cancer. It works by inhibiting the enzymes responsible for the proliferation of cancer cells and induces cell death (apoptosis). As a result, the growth and spread of cancer cells stopped or slowed down. Take 10 Veenat 400 mg tablets as prescribed by your doctor. It is recommended that you take 10 Veenat 400 mg tablets according to your doctor's condition, as long as your doctor has prescribed it for you. In s...
Read more